Press Releases for the Psychedelics Industry

Psychedelics News

Press Releases

Breaking News, Press Releases, Psychedelic Groundbreakers, Psychedelic Titans, Science

28 Aug 2025

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

AbbVie’s quiet acquisition of Gilgamesh Pharmaceuticals, reportedly worth close to $1 billion, did more than make headlines. It signaled something far more significant: Big Pharma has officially entered the psychedelic-adjacent...

By Madison Roberts

Breaking News, Industry, Press Releases, Psychedelic Groundbreakers, Science

23 Jul 2025

Enveric’s Latest Patent Signals a Clear Path Forward for PTSD Drug Development

This week, Enveric announced it has received a second U.S. patent allowance for compounds in its EVM401 Series, expanding its growing intellectual property fortress. These aren’t just any molecules —...

By Madison Roberts

Breaking News, Health & Wellness, Industry, Press Releases, Psychedelic Groundbreakers, Psychedelic Titans, Science

15 Jul 2025

Enveric’s EB-003 Shows Promise in PTSD Model, Offering a New Direction in Trauma Treatment

Enveric Biosciences announced that its lead compound, EB-003, significantly reduced trauma-related fear behaviors in a preclinical PTSD model—highlighting its potential as a fast-acting, non-hallucinogenic treatment for a condition with few...

By Madison Roberts

Breaking News, Press Releases, Science

3 Jun 2025

Enveric’s Patent Win Targets New Frontiers in Sleep Medicine

With U.S. Patent No. 12,187,679 now granted, Enveric Biosciences has secured more than intellectual property—it’s staked a claim on the future of neurotherapeutics. The Cambridge-based biotech firm announced this week...

By Madison Roberts

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

13 Nov 2024

Enveric and MycoMedica’s New Licensing Agreement Marks a Strategic Shift in Mental Health Treatment

In a groundbreaking collaboration, Enveric Biosciences has signed a licensing agreement with MycoMedica Life Sciences, granting exclusive rights to develop and commercialize its psilocin-based drug candidate, EB-002. This deal, potentially...

By Madison Roberts

Breaking News, Press Releases

15 Oct 2024

Enveric Biosciences Unveils Positive Safety and Pharmacology Data for EB-003

New preclinical results showcase EB-003’s ability to target serotonergic receptors while minimizing risks of cardiovascular and CNS side effects, advancing its potential as a non-hallucinogenic treatment for mental health disorders....

By Madison Roberts

Press Releases

2 Aug 2024

Adamo Bioscience Unveils the Adamo Method: A Revolutionary Advancement in Sexual Medicine

Adamo Bioscience introduces the Adamo Method, a groundbreaking advancement in sexual medicine. Developed by Dr. Molly Maloof, Dr. Saida Desilets, and Aaron Michael, this innovative approach significantly improves sexual satisfaction...

By Madison Roberts

Press Releases

25 Jul 2024

Enveric Biosciences Announces Promising Preclinical Results for EB-003

Enveric Biosciences has announced promising preclinical results for their novel drug candidate, EB-003. The findings highlight the drug’s potential for oral administration and significant brain exposure in rodent models. These...

By Madison Roberts

Press Releases

16 Jul 2024

Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement

Enveric Biosciences (NASDAQ: ENVB), a biotechnology company focused on developing novel neuroplastogens for neuropsychiatric disorders, and Aries Science & Technology, a developer of encapsulation technologies, have announced a licensing agreement...

By Madison Roberts

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result